API's
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients
Mesalamine SR Pellets are designed to provide sustained-release delivery of Mesalamine (5-aminosalicylic acid), an anti-inflammatory agent commonly used for the treatment of inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn’s disease. These pellets utilize advanced polymer-coating technology to enable controlled drug release over a 12–24 hour period, helping maintain consistent therapeutic levels in the gastrointestinal tract and improving patient compliance.
| Component | Function |
|---|---|
| Mesalamine | Active Pharmaceutical Ingredient (API) |
| Microcrystalline Cellulose (MCC) | Inert core / Neutral starter spheres ensuring mechanical strength and uniform pellet size |
| Hydroxypropyl Methylcellulose (HPMC) | Binder and film former for uniform drug layering and initial controlled release |
| Ethyl Cellulose | Sustained-release polymer controlling drug release rate and protecting from moisture |
| Polyvinyl Acetate (PVAc) | Additional polymer for enhanced moisture barrier and improved film flexibility |
| Triethyl Citrate (TEC) | Plasticizer to provide flexibility and prevent cracking of polymer coatings |
| Colloidal Silicon Dioxide | Glidant and anti-adherent to improve powder flow and reduce pellet sticking during coating |
| Magnesium Stearate | Lubricant to improve pellet flow during processing |
| Purified Water | Solvent, evaporated during processing |
Salius Pharma offers Mesalamine SR Pellets manufactured in USFDA-approved, WHO-GMP, and ISO-certified facilities in India. Our manufacturing process ensures full compliance with international regulatory standards and utilizes advanced pelletization and polymer coating technologies to deliver consistent, controlled drug release and enhanced stability. Available in a range of customizable strengths and pellet sizes, these pellets are ideally suited for oral sustained-release formulations targeting inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Mesalamine SR Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
Salius Pharma offers flexible MOQs starting from 50 kilograms, allowing pharmaceutical companies to cater to both pilot-scale and full commercial production needs across global markets.
Our products are manufactured in USFDA-approved, WHO-GMP, and ISO-certified facilities. We provide complete regulatory documentation, including Certificates of Analysis, Certificates of Origin, and GMP compliance certificates to meet diverse country-specific import requirements.
Yes, we offer customizable packaging and private labeling solutions compliant with regional regulatory standards, ensuring your product meets local market requirements and shelf-life expectations during transit.
We partner with reliable global logistics providers to offer flexible shipping options, including air and sea freight. Our experienced supply chain team coordinates export documentation and customs clearance to ensure timely and secure delivery worldwide.